Asim Mohammad, El-Menyar Ayman, Peralta Ruben, Arumugam Suresh, Wahlen Bianca, Ahmed Khalid, Khan Naushad Ahmad, Alansari Amani N, Mollazehi Monira, Ibnas Muhamed, Al-Hassani Ammar, Parchani Ashok, Chughtai Talat, Galwankar Sagar, Al-Thani Hassan, Rizoli Sandro
Clinical Research, Trauma and Vascular Surgery, Hamad Medical Corporation, Doha P.O. Box 3050, Qatar.
Clinical Medicine, Weill Cornell Medical College, Doha P.O. Box 3050, Qatar.
Diagnostics (Basel). 2025 Apr 30;15(9):1148. doi: 10.3390/diagnostics15091148.
: We aimed to evaluate the clinical significance of abnormal rotational thromboelastometry (ROTEM) findings in trauma patients and investigate the relationships between FIBTEM-maximum clot firmness (MCF), fibrinogen concentration and patient outcomes. : A retrospective cohort analysis was conducted on adult trauma patients who underwent on-admission ROTEM testing between January 2020 and January 2021. Univariate analyses compared data based on injury severity, ROTEM findings (normal vs. abnormal), and initial fibrinogen concentration (normal vs. hypofibrinogenemia). ROC curve analysis was performed to determine the diagnostic performance of FIBTEM A10/MCF for its association with hypofibrinogenemia. : A total of 1488 patients were included in this study; the mean age was 36.4 ± 14.2 years and 92% were male. In total, 376 (25.3%) patients had ROTEM abnormalities. Severe injuries (ISS ≥ 16) were associated with a higher shock index, positive troponin T levels, standard coagulation abnormalities, hypofibrinogenemia, and abnormal ROTEM parameters ( < 0.05). These patients also had higher rates of massive transfusions and in-hospital mortality ( = 0.001). Coagulation alterations were significantly associated with higher injury severity score (ISS), shock index, head abbreviated injury score (AIS), hypofibrinogenemia, transfusion need, and mortality ( < 0.05). Hypofibrinogenemic patients were younger, sustained severe injuries, had higher shock indices and coagulation marker levels, required more intensive treatments, had longer hospital stays, and had higher mortality ( < 0.05). A significant positive correlation was found between plasma fibrinogen concentration and FIBTEM-MCF (r = 0.294; = 0.001). : Approximately one-fourth of the patients had early traumatic coagulopathy, as assessed by ROTEM. The FIBTEM A10/MCF may serves as a surrogate marker for plasma fibrinogen concentration. While prior studies have established the link between ROTEM and injury severity, our findings reinforce its relevance across varying trauma severity levels. However, prospective studies are warranted to validate its role within diverse trauma systems and evolving resuscitation protocols.
我们旨在评估创伤患者旋转血栓弹力图(ROTEM)异常结果的临床意义,并研究纤维蛋白原检测最大血凝块硬度(MCF)、纤维蛋白原浓度与患者预后之间的关系。
对2020年1月至2021年1月期间入院时接受ROTEM检测的成年创伤患者进行回顾性队列分析。单因素分析根据损伤严重程度、ROTEM结果(正常与异常)以及初始纤维蛋白原浓度(正常与低纤维蛋白原血症)对数据进行比较。进行ROC曲线分析以确定FIBTEM A10/MCF与低纤维蛋白原血症相关性的诊断性能。
本研究共纳入1488例患者;平均年龄为36.4±14.2岁,92%为男性。共有376例(25.3%)患者存在ROTEM异常。严重损伤(损伤严重度评分[ISS]≥16)与较高的休克指数、肌钙蛋白T水平阳性、标准凝血异常、低纤维蛋白原血症和ROTEM参数异常相关(P<0.05)。这些患者大量输血率和院内死亡率也较高(P=0.001)。凝血改变与较高的损伤严重度评分(ISS)、休克指数、头部简明损伤评分(AIS)、低纤维蛋白原血症、输血需求和死亡率显著相关(P<0.05)。低纤维蛋白原血症患者更年轻,遭受严重损伤,休克指数和凝血标志物水平更高,需要更强化的治疗,住院时间更长,死亡率更高(P<0.05)。血浆纤维蛋白原浓度与FIBTEM-MCF之间存在显著正相关(r=0.294;P=0.001)。
根据ROTEM评估,约四分之一的患者存在早期创伤性凝血病。FIBTEM A10/MCF可作为血浆纤维蛋白原浓度的替代标志物。虽然先前的研究已经确立了ROTEM与损伤严重程度之间的联系,但我们的研究结果强化了其在不同创伤严重程度水平上的相关性。然而,需要进行前瞻性研究以验证其在不同创伤系统和不断发展的复苏方案中的作用。